title: Preventing death in the catastrophic antiphospholipid (Asherson) syndrome.
authors: Systemic Autoimmune Disease Research Unit, HGR#36, Instituto Mexicano del Seguro Social, Puebla, México. 30591mgc@comb.es
authors: Mario
authors: M
authors: García-Carrasco
authors: Ricardo O
authors: RO
authors: Escárcega
authors: Claudia
authors: C
authors: Mendoza-Pinto
authors: Alfonso
authors: A
authors: Zamora-Ustaran
authors: Ivet
authors: I
authors: Etchegaray-Morales
authors: Jorge
authors: J
authors: Rojas-Rodriguez
authors: Luis E
authors: LE
authors: Escobar-Linares
authors: Ricard
authors: R
authors: Cervera
mesh_terms: D000328:Adult; D000465:Algorithms; D016736:Antiphospholipid Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D015897:Comorbidity; D003422:Critical Care; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000453:epidemiology; D008775:Methylprednisolone / Q000627:therapeutic use
chemical_list: D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D008775:Methylprednisolone